Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Augustin

Showing results (141-150 of 568) with videos related to

Pageof 57
Sort By:
Acta Dermato-Venereologica|February 7, 2024
Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims DataValerie Andrees, Sandra Wolf, Marie Sander, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|November 27, 2015
Epidemiology of chronic wounds in Germany: Analysis of statutory health insurance dataKristina Heyer, Katharina Herberger, Kerstin Protz, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 30, 2019
[Access to statutory skin cancer screening : Organizational and regional factors in Germany]Valerie Andrees, Gefion Girbig, Magdalene Krensel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Digital health interventions in dermatology-Mapping technology and study parameters of systematically identified publicationsPatrick Reinders, Matthias Augustin, Natalia Kirsten, et al.
Plos One|March 22, 2022
Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variationsJobst Augustin, Sandra Wolf, Brigitte Stephan, et al.
Acta Dermato-Venereologica|February 20, 2010
Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in GermanyMatthias Augustin, Kristian Reich, Gerd Glaeske, et al.
Multiple Sclerosis and Related Disorders|January 15, 2019
Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaireHelen Beckmann, Matthias Augustin, Christoph Heesen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]Thomas Luger, Michael Reusch, Kristian Reich, et al.
Archives of Dermatological Research|December 26, 2012
Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilitiesChristine Blome, Florian C Beikert, Stephan J Rustenbach, et al.
Patient Preference and Adherence|June 7, 2023
Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea TreatmentMatthias Augustin, Rachel Sommer, Christine Blome, et al.
Pageof 57

Showing results (141-150 of 568) with videos related to

Sort By:
Pageof 57
Acta Dermato-Venereologica|February 7, 2024
Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims DataValerie Andrees, Sandra Wolf, Marie Sander, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|November 27, 2015
Epidemiology of chronic wounds in Germany: Analysis of statutory health insurance dataKristina Heyer, Katharina Herberger, Kerstin Protz, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 30, 2019
[Access to statutory skin cancer screening : Organizational and regional factors in Germany]Valerie Andrees, Gefion Girbig, Magdalene Krensel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Digital health interventions in dermatology-Mapping technology and study parameters of systematically identified publicationsPatrick Reinders, Matthias Augustin, Natalia Kirsten, et al.
Plos One|March 22, 2022
Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variationsJobst Augustin, Sandra Wolf, Brigitte Stephan, et al.
Acta Dermato-Venereologica|February 20, 2010
Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in GermanyMatthias Augustin, Kristian Reich, Gerd Glaeske, et al.
Multiple Sclerosis and Related Disorders|January 15, 2019
Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaireHelen Beckmann, Matthias Augustin, Christoph Heesen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]Thomas Luger, Michael Reusch, Kristian Reich, et al.
Archives of Dermatological Research|December 26, 2012
Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilitiesChristine Blome, Florian C Beikert, Stephan J Rustenbach, et al.
Patient Preference and Adherence|June 7, 2023
Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea TreatmentMatthias Augustin, Rachel Sommer, Christine Blome, et al.
Pageof 57